On July 8, 2013, Michael Iseman resigned as a member of the Board of Directors of Omni Bio Pharmaceutical, Inc. Iseman is resigning for personal reasons and is not resigning because of a disagreement with the company or on any matter relating to its operations, policies or practices.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | +66.67% | +233.33% |
2016 | Omni Bio Pharmaceutical, Inc. cancelled the transaction announced on March 16, 2015 | CI |
2015 | Omni Bio Pharmaceutical, Inc. Announces Management Changes | CI |
1st Jan change | Capi. | |
---|---|---|
+233.33% | 50.06T | |
+15.06% | 12TCr | |
+12.77% | 11TCr | |
-5.27% | 2.48TCr | |
+1.69% | 2.25TCr | |
-10.09% | 1.83TCr | |
-42.28% | 1.63TCr | |
-15.20% | 1.53TCr | |
+2.76% | 1.41TCr | |
+25.18% | 1.17TCr |
- Stock Market
- Equities
- OMBP Stock
- News Omni Bio Pharmaceutical, Inc.
- Omni Bio Pharmaceutical, Inc. Announces Resignation of Michael Iseman as Member of the Board of Directors